
40
0.23%
—
—
Low Risk
0.15
—
38.03
47.83
0.921
—
Bullish
83.66
43.50
44.10
| Company | Weightage (%) |
| Sun Pharmaceutical Industries Ltd. | 13.20% |
| Divis Laboratories Ltd. | 6.00% |
| Cipla Ltd. | 5.90% |
| Dr Reddys Laboratories Ltd. | 5.80% |
| Apollo Hospitals Enterprise Ltd. | 5.60% |
| Max Healthcare Institute Ltd. | 5.50% |
| Lupin Ltd. | 4.10% |
| Fortis Healthcare Ltd. | 3.50% |
| Torrent Pharmaceuticals Ltd. | 3.20% |
| Laurus Labs Ltd. | 2.90% |
Allocation
69.13
▼ 0.93%
99.22
▼ 0.32%
151.17
▲ 1.89%
26.18
▼ 1.39%
240.03
▲ 3.68%
60.69
▼ 0.98%
79.20
▼ 1.28%
38.59
▼ 0.69%
82.00
▼ 2.14%
194.52
▼ 0.81%
104.66
▼ 0.89%
229.47
▲ 0.61%
33.62
▼ 1.44%
124.23
▼ 0.33%
36.41
▼ 0.60%
88.50
▼ 1.30%
16.10
▼ 1.47%
33.08
▼ 0.84%
46.84
▼ 1.99%
23.90
▼ 0.91%
43.57
▼ 1.20%
30.86
▼ 1.18%
50.80
▼ 0.74%
155.69
▼ 0.42%
63.97
▼ 1.39%
63.79
▲ 0.46%
43.97
▲ 0.30%
63.70
▼ 0.93%
51.88
▼ 0.84%
63.14
▼ 1.19%
265.92
▼ 1.12%
The current market price of Motilal Oswal S&P BSE Healthcare ETF is ₹43.97. ETF prices fluctuate during market hours based on demand, supply, and movements in the underlying index or assets.
The Motilal Oswal S&P BSE Healthcare ETF, managed by Motilal Oswal Asset Management Company Limited, aims to replicate the total returns of the BSE Healthcare Total Return Index, focusing on passive investment. This ETF emphasizes a concentrated portfolio in the healthcare sector, with top holdings like Sun Pharmaceutical Industries Ltd. at 12.8% and a significant allocation in Pharmaceuticals & Biotechnology at 73.5%. Over the past three years, the fund has demonstrated a robust CAGR of 23.3%, although it experienced a slight decline of -1.96% over the last year, highlighting performance volatility. The expense ratio stands at a competitive 0.23%, and the fund size is approximately ₹32.76 Cr, indicating efficient management relative to its scale and complexity. The portfolio is managed by experienced professionals, including Mr. Swapnil Mayekar, who has 20 years of experience, providing a stable leadership for navigating market dynamics.
Motilal Oswal S&P BSE Healthcare ETF is designed to track BSE Healthcare Total Return Index, allowing investors to gain exposure to its underlying securities through a single investment.
The expense ratio of Motilal Oswal S&P BSE Healthcare ETF is 0.23%. This represents the annual fee charged by the fund house for managing the ETF and is deducted from the fund’s assets.
The Assets Under Management (AUM) of Motilal Oswal S&P BSE Healthcare ETF is approximately ₹40.21. AUM reflects the total market value of assets managed by the ETF and is often used as an indicator of fund size and liquidity.
Motilal Oswal S&P BSE Healthcare ETF is classified under the as per the risk-o-meter defined by the fund house risk category. The risk level depends on the volatility of the underlying index, market conditions, and asset composition of the ETF.
The tracking error of Motilal Oswal S&P BSE Healthcare ETF is depends on how closely the ETF follows its benchmark. Tracking error measures how closely the ETF’s performance matches its benchmark index over time.
Motilal Oswal S&P BSE Healthcare ETF does not currently declare dividends and may reinvest earnings into the fund. Dividend treatment depends on the ETF structure and fund house policy.
Based on available data, Motilal Oswal S&P BSE Healthcare ETF has delivered the following returns: 1-year return: 7.77%. 3-year return: 97.92%. 5-year return: 89.95%. Past performance does not guarantee future results.
Before investing in Motilal Oswal S&P BSE Healthcare ETF, investors generally consider the underlying index, expense ratio, tracking error, risk profile, liquidity, and how the ETF fits within their overall portfolio strategy.

AUM
₹ 40 Cr
Expense Ratio
0.23%
Bearish
8
Neutral
3
Bullish
3
Bearish
16
Neutral
3
Bullish
27
Bearish
8
Neutral
0
Bullish
24
Performance
UNDER PERFORMER
Technicals
Bullish
Risk
—
Liquidity
NEUTRAL
Consistency
GOOD